Skip to main content

José Alegre Martin

Institutions of which they are part

Rheumatology
Vall Hebron Institut de Recerca

José Alegre Martin

Institutions of which they are part

Rheumatology
Vall Hebron Institut de Recerca

Projects

Ensayo clínico, aleatorizado, controlado, paralelo, para evlauar la eficacia de dos técnicas de acupuntura validad en salud: Somatoacupuntura versus Auriculopuntura, como tratamiento en los pacientes diagnosticados con Síndrome de Fatiga Crónica

IP: -
Collaborators: José Alegre Martin
Funding agency: Col·legi Oficial d'Infermers/es de Barcelona
Funding: 2420
Reference: COIB-2725-12
Duration: 01/01/2013 - 31/12/2014

Ensayo clínico, aleatorizado, controlado, paralelo, doble ciego, para evaluar eficacia-seguridad de alteplasa vs uroquinasa intrapleurales como tratamiento del derrame paraneumónico complicado complejo y empiema

IP: Maria Carmen Aleman Llanso
Collaborators: Ana Vázquez Suárez, J. Bruno Montoro Ronsano, José Alegre Martin, Tomás Fernández de Sevilla Ribosa, María Deu Martín, Jordi Andreu Soriano, Teresa Soriano Sánchez, Pilar Suñe Martin, Eva Ruiz Ruiz
Funding agency: Instituto de Salud Carlos III
Funding: 82885
Reference: EC07/90479
Duration: 01/11/2007 - 30/06/2011

Registro de base poblacional de los pacientes afectos del síndrome de fatiga crónica

IP: José Alegre Martin
Collaborators: Eva Ruiz Ruiz
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 38000
Reference: FMMA/14/2006
Duration: 04/05/2007 - 01/10/2010

Repercusión funcional de la alteración neurovegetativa en los pacientes con el síndrome de fatiga crónica

IP: José Alegre Martin
Collaborators: Montserrat Duran Taberna, Eva Ruiz Ruiz
Funding agency: Instituto de Salud Carlos III
Funding: 51170
Reference: PI050200
Duration: 01/01/2006 - 31/12/2008

Related news

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

The session focused on the scientific, regulatory and clinical challenges of advanced therapy medicinal products, from preclinical research to first-in-human trials.

Related professionals

Lourdes Zamorano Moreno

Lourdes Zamorano Moreno

Gestió i Administració
General Services and Infrastructures Unit
Infrastructure Coordination
Manager
Read more
Daniel Eiroa Gutierrez

Daniel Eiroa Gutierrez

Research technician
Molecular Imaging and Therapy
Read more
Cándido Muñoz Muñoz

Cándido Muñoz Muñoz

Predoctoral researcher
Systemic Diseases
Read more
Josep Paunellas Albert

Josep Paunellas Albert

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.